NME1 and cancer: On the other hand, reexpression of NME1 in invasive cancer cells has been thought to be a promising strategy for antimetastatic therapy (33, 34); our results indicate that the suppression of NME1 by LCFA-CoA needs to be considered in future clinical practice.